✦ LIBER ✦

PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer: Does Severity Matter?

✍ Scribed by Wilson, L.S.; Zhong, L.; Pon, V.; Srinivas, S.; Frear, M.; Nguyen, N.; Gong, C.; Kwon, S.; Malmstrom, R.; Loucks, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abiraterone Acetate Versus Enzalutamide

✍ He, J.; Li, T.; Saadi, R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

New therapeutic options in metastatic ca

✍ Wilson, L.; Tang, J.; Zhong, L.; Balani, G.; Gipson, G.; Xiang, P.; Yu, D.; Srin 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 296 KB

128 COST-EFFECTIVE ANALYSIS (CEA) OF THE

✍ Pollard, Matthew; Moskowitz, Alan; Oh, William; Galsky, Matthew; Hall, Simon 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 58 KB

Cost-Effectiveness Analysis of Abiratero

✍ Shibahara, H.; Shiroiwa, T.; Nakamura, K.; Shimozuma, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN46 Cost-Efficacy Analysis of Licensed

✍ S. Ostalé; P. Ruiz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost Effectiveness Analysis Of Abiratero

✍ Persson, U.; Nilsson, S.; Prûtz, C.; Hjortsberg, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB